Indian drug manufacturers who have signed up with Russia’s RDIF to produce Sputnik V are struggling to scale up production of the second component of the Covid-19 vaccine, and are now counting on the approval for the single-shot Sputnik Light to salvage the situation, reports Viswanath Pilla. A top executive …
Read More »India to get Russia’s Sputnik V vaccine only by end-May, Health News, ET HealthWorld
India will start receiving Russia’s Sputnik V Covid-19 vaccine by end-May, its local distributor Dr. Reddy’s Laboratories told Reuters on Thursday, a later than expected schedule that could slow the country’s immunisation drive. “We are targeting to have the first batches imported by (fiscal) Q1, and are trying our best …
Read More »Russia’s Sputnik V gets Emergency Use authorisation nod in India, Health News, ET HealthWorld
New Delhi: Russia’s Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to get clearance in India. According to sources, the SEC approved Dr Reddy’s application for EUA to Sputnik V. The decision comes after the Drugs Controller …
Read More »India drug regulator asks Dr.Reddy’s for more data on Sputnik V COVID-19 vaccine
An expert panel of India’s drug regulator on Friday sought additional data from drugmaker Dr.Reddy’s Laboratories on its Sputnik V COVID-19 vaccine trial, in its second such request after an initial evaluation in February. The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both …
Read More »